To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Alzheimer’s disease (AD)
In vitro and mouse studies identified a dual PDE-5/HDAC inhibitor that could help treat AD. Chemical synthesis and in vitro
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury